selegiline has been researched along with n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazumura, K; Maruyama, W; Naoi, M; Osawa, T; Wu, Y | 1 |
1 other study(ies) available for selegiline and n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
| Article | Year |
|---|---|
Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection.
Topics: Apoptosis; Calcium; Cell Line, Tumor; Cyclosporine; Cytoplasm; Humans; Indans; Indoleacetic Acids; Isoquinolines; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Protoporphyrins; Receptors, GABA; Selegiline; Superoxides | 2015 |